Inactive Instrument

Premier Biomedical, Inc. Stock Other OTC

BIEI

US74048K2033

Chart Premier Biomedical, Inc.

Duration

Period

Style

Dynamic Chart

Latest news about Premier Biomedical, Inc.

Premier Graphene, Inc. Appoints Gustavo Carreño as Chief Technology Officer	Mar. 07	CI
Nova-Graphene Ballistics, Inc. Announces Agreements to Manufacture its Revolutionary 3D-Printed Ballistic Armor Using its Proprietary Graphene Production Methodology	22-12-20	CI
Itaú Unibanco S A : Brazilian billionaire Lemann leads initiative to build COVID-19 vaccine factory	20-08-07	RE
William A. Hartman Resigns as Chief Executive Officer of Premier Biomedical, Inc	20-06-01	CI
Heidi H. Carl Resigns as Chief Financial Officer of Premier Biomedical, Inc	20-06-01	CI
Premier Biomedical, Inc. Announces Executive Changes	20-06-01	CI
Premier Biomedical, Inc. Appoints David Caplan to the Board of Directors	20-06-01	CI
Premier Biomedical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-05-15	CI
Premier Biomedical, Inc. Announces Resignation of Mitchell Felder as Chairman and Member of Board of Directors	20-05-07	CI
Premier Biomedical, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-14	CI
Premier Biomedical, Inc. announced that it has received $0.025 million in funding from Green Coast Capital International S.A.	19-10-02	CI
Premier Biomedical, Inc. announced that it expects to receive $5 million in funding from Green Coast Capital International S.A.	19-09-25	CI
Premier Biomedical, Inc. announced that it has received $0.043 million in funding from PowerUp Lending Group, Ltd.	19-08-15	CI
Premier Biomedical, Inc. announced that it expects to receive $0.043 million in funding from PowerUp Lending Group, Ltd.	19-08-14	CI
Premier Biomedical, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-14	CI

More news

Press releases Premier Biomedical, Inc.

Premier Graphene, Inc. (BIEI) Demonstrates Industry-Leading Innovations with Graphene-Enhanced Building Materials	Apr. 17	AQ
Premier Biomedical Inc. (BIEI), now known as Premier Graphene, Inc., engages Gustavo Carreño as Chief Technology Officer (CTO)	Mar. 07	AQ
Premier Biomedical Inc. (OTC: BIEI), Welcomes Officers, Directors and Key Advisors	23-03-30	AQ
Premier Biomedical Inc. (OTC: BIEI), now known as Premier Graphene, Inc., specifies plans and timing for development of its Full Scale, Seed To Product Delivery, Graphene Initiative	23-02-28	AQ
Nova Graphene Ballistics (OTC PINK: BIEI) Retains Award Winning Communication Firm To Expand Public Messaging	23-02-01	AQ

More press releases

Managers and Directors - Premier Biomedical, Inc.

Managers	Title	Age	Since
Gabe Vlad DFI	Director of Finance/CFO	-	-
William Tynan AUD	Comptroller/Controller/Auditor	-	-
Brain A. Lebrecht LAW	General Counsel	-	-

More insiders

Premier Graphene, Inc. is a global advanced materials firm with a focus on research, production and marketing of eco-friendly graphene. The Companyâs graphene and novel additive formulations are integrated into the production process of other products. The Company is engaged in supplying large-scale industrial quantities. Its proprietary graphene blends and formulations target specific product enhancements sought by manufacturers.

Sector

Specialty Chemicals

More about the company

Sector Other Specialty Chemicals

	1st Jan change	Capi.
ECOLAB INC.	+10.74%	62.8B
SIKA AG	-5.48%	45.4B
GIVAUDAN SA	+14.81%	40.32B
FUJIFILM HOLDINGS CORPORATION	+20.63%	25.83B
EMS-CHEMIE HOLDING AG	+5.51%	18.21B
CELANESE CORPORATION	+0.46%	17.41B
SYMRISE AG	+4.12%	15.64B
POSCO FUTURE M CO., LTD.	-23.40%	15.51B
ALBEMARLE CORPORATION	-20.96%	13.42B

Other Specialty Chemicals

Sales 2018	0.04	Sales 2019	0.01	Capitalization	78.42K
Net income 2018	-	Net income 2019	-	EV / Sales 2018	16,149,039 x
Net Debt 2018	223K	Net Debt 2019	89.55K	EV / Sales 2019	11,762,132 x
P/E ratio 2018	-0.74 x	P/E ratio 2019	-0.06 x	Employees	-
Yield 2018 *	-	Yield 2019	-	Free-Float	99%